Innventa pharm

What Innventa pharm does

Innventa Pharm d.o.o. is a privately held Serbian specialty pharmaceutical company headquartered in Belgrade (with a representative office in Vršac) that develops, imports, and distributes proprietary pharmaceutical products across three regulatory categories: dietary supplements, medical devices, and prescription drugs. The company operates a branded portfolio of approximately 30+ SKUs organized around five therapeutic verticals — urology (Urolitinn, Graminn, Sperginn Forte, Longupinn, Instylan), orthopedics/physiatry (Fortinn, Fortinn Strong, Forticolinn, Tendocolinn, Innopea, R-Lipoinn, Bomelinn, Innurid), gynecology (Innovag, Biofeminn, Innofer, Luprinn), cardiology (Nattokinn, Oligopinn), and ENT (Laringinn, Rhinosinn) — plus a small Rx line (Nitrofinn, Ginominn, Talinorm, Kolhinn, Duopresinn, Metaspon, Vinpocetin, Dienogest Aristo, Ebastin Aristo).

Product differentiation rests on inbound-licensed patented technologies sourced from 20+ international partners primarily in Spain, Greece, Italy, Argentina, and the United States, including LipiSperse/Levagen+ (PEA delivery), Bromeyal (multi-step pineapple-peel bromelain extraction), FORTIGEL/FORTIBONE/TENDOFORTE (bioactive collagen peptides for joint, bone, and tendon indications), DRcaps (acid-resistant hypromellose capsules protecting R-alpha-lipoic acid), and SynBalance (Lactobacillus/Bifidobacterium probiotic blends). Clinical support includes 30+ PEA studies covering 6,000+ patients. Innventa characterizes its portfolio as deliberately non-me-too, with proprietary or exclusively licensed formulations vs. generic competitors.

Innventa's revenue model combines pharmaceutical product sales, wholesale import/distribution margins, and own-brand (Innventa) product development pivoted in March 2016. Go-to-market is sales-led: ~30 medical representatives target physicians, pharmacists, pharmacies, hospitals, and registered wholesalers (veledrogerije) across Serbia, Bosnia and Herzegovina, Montenegro, North Macedonia, Albania, Slovakia, Spain, Russia, and (most recently) Greece, with planned extension to Romania, Hungary, and Bulgaria. Pricing is not publicly disclosed. The company has no disclosed external funding or institutional investors and is controlled by an ownership group that took over in 2015; Goran Orlić has served as General Manager since 2015 alongside Commercial Director Milorad Dragojlović. The company has been described by management as the fastest-growing pharma in Serbia for several consecutive years and ranked top 35 by revenue within 5 years of operation.

Name

Innventa pharm

Legal name

Innventa pharm d.o.o.

Website

https://innventa-pharm.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Innventa Pharm is a Belgrade-based private pharmaceutical company that develops, imports, and distributes proprietary dietary supplements, medical devices, and prescription drugs across urology, orthopedics, gynecology, cardiology, and ENT indications, sold via medical representatives to pharmacies, hospitals, and wholesalers across 8+ Balkan and CEE markets.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Care Pharmaceuticals (HLAIAAAB)

akta.pro secondary industries

Nephrology & Urology Pharmaceuticals (HLAIAAAM), Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)

Keywords

• Pharmaceutical products
• Dietary supplements
• Medical devices
• Prescription drugs
• Pharmaceutical distribution

Headquarters

HQ city

Belgrade

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Marketing or Sales, Operations, Supply Chain, Technology or R&D

Revenue model

1. Pharmaceutical Product Sales: Sale of proprietary pharmaceutical products including dietary supplements, medical devices, and prescription drugs through pharmacies, hospitals, and medical institutions across Serbia and regional markets
2. Import and Distribution: Registered as importer and wholesaler specializing in representation of pharmaceutical companies, import and distribution, and promotions. Revenue generated from margin on imported and distributed products
3. Own Brand Product Development: Since 2016, focus on product development under own brand (Innventa brand products), generating revenue from proprietary formulations sold through distribution network

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Innventa Pharm develops, imports, and distributes pharmaceutical products including dietary supplements, medical devices, and prescription drugs across therapeutic categories such as urology, orthopedics, gynecology, cardiology, and ENT. The company combines representation of partner pharmaceutical companies with proprietary own-brand product development using patented formulations (e.g., Levagen+, Bromeyal, FORTIGEL, SynBalance) sold through pharmacies, hospitals, and wholesalers across the Balkans and broader European markets.

Product overview

Innventa Pharm is a pharmaceutical company offering a portfolio of dietary supplements, medical devices, and prescription drugs. The company operates across therapeutic categories including urology (Urolitinn®, Graminn®, Instylan, Sperginn® Forte, Longupinn®), orthopedics/physiatry (Fortinn®, Fortinn® Strong, Fortinn® gels, Forticolinn®, Tendocolinn®, Innopea®, R-Lipoinn®, Bomelinn®, Innurid®), gynecology (Innovag®, Biofeminn®, Innofer®, Luprinn®), cardiology (Nattokinn®, Oligopinn®), ENT (Laringinn®, Rhinosinn®), and other supplements (Hemoprinn®, IMUNITINN® C+Zn direct). The company also markets prescription drugs including Nitrofinn®, Ginominn®, Talinorm®, Dienogest Aristo, Ebastin Aristo, Duopresinn®, Metaspon®, Vinpocetin, and Kolhinn®.

Differentiator

Problem solved

Functional benefit

Products and services

• Urolitinn® Product in Innventa Pharm's urology portfolio for urological conditions. Sold through pharmacies.
• Graminn® (including suppositories and Forte variants) Urology product with variants including suppositories and Forte formulation for urological applications.
• Instylan Product in Innventa Pharm's urology portfolio. Sold through pharmacies.
• Sperginn® Forte Male reproductive health supplement containing L-arginine, taurine, vitamin C, vitamin E, coenzyme Q10 and zinc for sperm quality and fertility support.
• Longupinn® Product in Innventa Pharm's urology portfolio, addressing male reproductive health concerns.
• Fortinn® (including Strong variant) Joint health supplement with bioactive collagen peptides (FORTIGEL®B) for osteoarthritis therapy, improving joint mobility and reducing pain and inflammation; high-strength Fortinn Strong variant provides 10g of FORTIGEL-B peptides.
• Fortinn® gel COLD Topical gel with cooling effect containing thyme extract, menthol, camphor for pain relief and reduced inflammation in muscles and joints.
• Fortinn® gel HOT Topical warming gel with hot pepper extract and ginger for chronic muscle and joint pain relief.
• Forticolinn® Bone health supplement with FORTIBONE® bioactive collagen peptides and calcium lactate for osteoporosis and osteopenia treatment.
• Tendocolinn® (including SPORT variant) Tendon and ligament support supplement with TENDOFORTE®B bioactive collagen peptides for injury recovery and prevention; SPORT variant targeted at athletes.
• Innopea® (including Forte variant) Supplement with palmitoylethanolamide (PEA) using Levagen+ technology for chronic pain and inflammation reduction, nerve cell protection, and cognitive function optimization; Forte variant includes B vitamins for tension-type headache relief and immune system support.
• R-Lipoinn® Contains Sodium R-lipoate using DRcaps acid-resistant capsule technology for oxidative stress regulation in diabetes, diabetic neuropathy, obesity, and anti-aging; 2.5x higher bioavailability than standard alpha lipoic acid.
• Bomelinn® Bromelain-based supplement (Bromeyal®) for inflammation, swelling and pain reduction in musculoskeletal, reproductive and respiratory systems.
• Innurid® Nervous system support supplement with uridine-5-monophosphate and B complex vitamins for peripheral nerve damage recovery.
• Innovag® Vaginal ovules with chlorhexidine and propolis extract for treatment and prevention of vaginosis and bacterial/fungal vaginitis.
• Biofeminn® Vaginal flora supplement with probiotic strains (Lactobacillus, Bifidobacterium) using SynBalance® formulation for urinary and vaginal infection prevention.
• Innofer® Iron supplement with vitamins and beta-carotene for anemia treatment and blood count regulation.
• Luprinn® Hop cone extract supplement with 8-prenylnaringenin phytoestrogen for menopausal symptom relief.
• Nattokinn® Nattokinase NSK-SD® supplement with folic acid for cardiovascular disease prevention, blood clot reduction, and blood pressure regulation.
• Oligopinn® Maritime pine bark extract supplement (Oligopin®) for blood vessel protection, circulation improvement, and antioxidant support.
• Hemoprinn® Protective cream for internal and external hemorrhoidal conditions with horse chestnut, witch hazel, and aloe vera extracts.
• IMUNITINN® C+Zn direct Immune support supplement with vitamin C and zinc for immune system function and oxidative stress protection.
• Laringinn® Oral cavity and pharyngeal spray with natural oils for throat irritation relief and mucosa protection.
• Rhinosinn® Nasal spray for nasal congestion and runny nose relief, and rhinitis prevention.
• Prescription drug portfolio (Nitrofinn®, Ginominn®, Talinorm®, Dienogest Aristo, Ebastin Aristo, Duopresinn®, Metaspon®, Vinpocetin Innventa, Kolhinn®) Portfolio of prescription drugs including Nitrofinn® (nitrofurantoin 50mg) for UTIs, Ginominn® (clindamycin 100mg vagitories) for gynecological infections, Talinorm® (chlortalidone 25mg) for hypertension, Dienogest Aristo 2mg, Ebastin Aristo orodispersible tablets for allergies, Duopresinn® (olmesartan/amlodipine) for hypertension, Metaspon® (glucosamine 1500mg) for joint conditions, Vinpocetin Innventa (vinpocetine 5mg/10mg) for cognitive support, and Kolhinn® (colchicine 0.5mg).

Quantifiable outcome

• Top 35 pharmaceutical companies by revenue in Serbia within 5 years of operation
• +2 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered core.

• 20 Partner Companies WorldwidecoreStrategic or Co-development Partner · 1 January 2016Innventa collaborates with 20 partner companies worldwide for product development and distribution. Since 2016, focus has been on developing products under Innventa's own brand using these partnerships for formulation expertise and technology access.
• International Pharmaceutical Partners (Spain, Greece, Italy, Argentina, USA)coreStrategic or Co-development Partner · 1 January 2011Innventa portfolio includes products developed in collaboration with partners from Spain, Greece, Italy, Argentina, United States and other countries. These partnerships provide access to innovative formulations and patented technologies that form the basis of Innventa's competitive product portfolio.

Scale indicators4 records

Recent moves11 records

Expansion highlights5 records

Market position

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCb2JVmqHhwIkTucbLXKSeXg
• Facebookfacebook.com/INNventaPharm
• LinkedInlinkedin.com/company/innventa
• Instagraminstagram.com/innventa_pharm
• Xx.com/InnventaPharm

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innventa pharm